Emflaza® (deflazacort)
| Full Name | Emflaza® (deflazacort) |
| Drug | Emflaza |
| Manufacturer | PTC Therapeutics, Inc. |
| Route of Administration | Oral |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | Treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older |
| Disease | Duchenne Muscular Dystrophy (DMD) |
| Therapeutic Area | Neurology, Genetics |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-605-1524 |
| Fax Number | 877-765-6254 |
| Product Website | hcp.emflaza.com |
| Patient Resources | Alex Rezcalla Foundation, Jett Foundation, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy |